Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $86 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.2%

Neg 0% Neu 89.2% Pos 0%

Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $86 price target.